McDonough Mark D

Avg. Two Year Performance

(83%) Avg. Purchase Return
(35%) Compound
60% Avg. Sale Return
26% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(33%)(25%)(5%)(42%)(83%)
Purchase Success Rate1 of 21 of 21 of 20 of 20 of 2
Average Sale Return7%27%45%76%60%
Sale Success Rate1 of 22 of 22 of 22 of 21 of 2

CombiMatrix Corporation

Drugs » Biotechnology

President and CEO, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--